PAVLOVÁ, Šárka, A. RAWSTRON, R. ROSENQUIST and K. STAMATOPOULOS. Risk stratification – How to assess TP53 aberrations and IGHV gene somatic hypermutation status. In ERIC PRECEPTORSHIP. Realizing Precision Medicine in CLL: Why and How. Stresa, Itálie. 2023.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Risk stratification – How to assess TP53 aberrations and IGHV gene somatic hypermutation status
Authors PAVLOVÁ, Šárka, A. RAWSTRON, R. ROSENQUIST and K. STAMATOPOULOS.
Edition ERIC PRECEPTORSHIP. Realizing Precision Medicine in CLL: Why and How. Stresa, Itálie, 2023.
Other information
Type of outcome Requested lectures
Confidentiality degree is not subject to a state or trade secret
Organization unit Central European Institute of Technology
Changed by Changed by: Bc. Kateřina Kolesová, učo 112275. Changed: 12/1/2024 15:44.
PrintDisplayed: 30/7/2024 17:18